Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Frontiers in Aging Neuroscience|February 23, 2017
Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's DiseaseIna S Almdahl, Camilla Lauridsen, Per Selnes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 19, 2007
ELAVL4, PARK10, and the CeltsKristoffer Haugarvoll, Mathias Toft, Owen A Ross, et al.
Alzheimer'S Research & Therapy|January 31, 2018
Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's diseaseKalicharan Patra, Antoninus Soosaipillai, Sigrid Botne Sando, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2007
Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's diseaseMathias Toft, Ignacio F Mata, Owen A Ross, et al.
BMJ Open|December 20, 2022
Safety and efficacy of plasma transfusion from exercise-trained donors in patients with early Alzheimer's disease: protocol for the ExPlas studyAtefe R Tari, Helene Haugen Berg, Vibeke Videm, et al.
European Journal of Human Genetics : EJHG|October 16, 2008
Fine-mapping and candidate gene investigation within the PARK10 locusKristoffer Haugarvoll, Mathias Toft, Lisa Skipper, et al.
Acta Neuropathologica Communications|November 28, 2018
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's diseaseDaniel Twohig, Elena Rodriguez-Vieitez, Sigrid B Sando, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2010
Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's diseaseJan O Aasly, Carles Vilariño-Güell, Justus C Dachsel, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 29, 2017
A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission tomography imagingYi Mo, Julie Stromswold, Kimberly Wilson, et al.
Scientific Reports|December 29, 2018
Meta-analysis of Alzheimer's disease on 9,751 samples from Norway and IGAP study identifies four risk lociAree Witoelar, Arvid Rongve, Ina S Almdahl, et al.
Pageof 6